Monthly Archives: June 2013

Strategic Partnerships: The Key to Venture Capital in Industrial Biotech

cleantech1

This morning at BIO’s World Congress on Industrial Biotech, the Clean Tech Investor Sessions kicked off with a panel called, “Global Perspectives for Project Financing in Clean Technology.” Moderated by Taite McDonald, Senior Advisor, Energy & Clean Technology Government Initiatives, Wilson Sonsini Goodrich & Rosati, the panel consisted of dynamic, international experts including Dirk Den Ouden, Senior Manager, Kempen & Co Corporate Finance; Felipe Pereira, Sector Manager, AIB, Department of Chemical Industry, BNDES; Josko Bobanovic, Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Opens the 10th Annual World Congress on Industrial Biotechnology

WC_2013

Brent Erickson, executive vice president of BIO’s Industrial & Environmental Section, welcomed attendees to the 10th annual BIO World Congress on Industrial Biotechnology in Montreal with remarks and a special video at the opening plenary session: BIO is proud to welcome you to the tenth annual World Congress on Industrial Biotechnology. Eleven years ago, I approached our board with the idea of starting a new conference dedicated to industrial biotechnology. Some of those original board members Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , ,

Scientific American Worldview Scorecard Correlates with International Investment

MikeMay

Biotechnology innovation requires investment, and the Scientific American Worldview Scorecard can predict where investment goes. A recent analysis indicates that the ranking of countries in this Scorecard correlates with global investment. As a result, the Worldview Scorecard provides a valuable tool for any country interested in increasing its appeal to biotechnology investors. In short, the Worldview Scorecard uses a wide collection of data – compiled and analyzed by Yali Friedman – that generates a metric Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Myriad Supreme Court Decision: BIO’s Statement

4973532326_6c75ba32ba copy

Statement On U.S. Supreme Court Review Of Isolated DNA Patents Washington, D.C. (June 13, 2013) Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on  the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: “The Supreme Court today summarily ruled that so-called cDNA remains eligible for patenting.  cDNA is the commercially most important form of DNA used in biotechnology.  Today’s decision offers urgently-needed Read More >

Patently BIOtech  |  2 Comments  |  Email This Post
Tags: , , , ,

More Junk Science: Is the Carman Pig Study “Seralini 2.0”?

k7974-18-150x150

A new pig feeding study authored by Australian researcher Judy Carman, and Maurice, Iowa farmer Howard Vlieger, claims that pigs fed genetically modified (GM) corn and genetically modified (GM) soybean meal showed increased incidence stomach inflammation.  This study was authored by two veteran anti-biotech campaigners, Judy Carman and Howard Vlieger, and was published in an obscure online journal financed by the organic industry.  It reaches conclusions that are diametrically opposed to the great preponderance of Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , ,